Evidence map›Paper›PMID 36386684›Full record

ArticleFrontiers in microbiology2022

Nationwide and long-term molecular epidemiologic studies of mumps viruses that circulated in Japan between 1986 and 2017.

Minoru Kidokoro, Teiichiro Shiino, Tomohiro Yamaguchi, Eri Nariai, Hiroe Kodama, Keiko Nakata, Takako Sano, Keiko Gotou, Tomoko Kisu, Tomomi Maruyama and 27 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 18 institutions in 1 country.

Minoru KidokoroDepartment of Quality Assurance, Radiation Safety, and Information Management, National Institute of Infectious Diseases, Tokyo, Japan.
Teiichiro ShiinoCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Tomohiro YamaguchiPublic Hygiene Division, Gifu Prefectural Tono Region Public Health Center, Tajimi, Japan.
Eri NariaiDepartment of Health and Food Safety, Ishikawa Prefectural Institute of Public Health and Environmental Science, Kanazawa, Japan.
Hiroe KodamaDepartment of Health and Food Safety, Ishikawa Prefectural Institute of Public Health and Environmental Science, Kanazawa, Japan.
Keiko NakataDivision of Virology, Osaka Institute of Public Health, Osaka, Japan.
Takako SanoDivision of Microbiology, Kanagawa Prefectural Institute of Public Health, Chigasaki, Japan.
Keiko GotouDivision of Virology, Ibaraki Prefectural Institute of Public Health, Mito, Ibaraki, Japan.
Tomoko KisuVirus Research Center, Clinical Research Division, Sendai National Hospital, Sendai, Japan.
Tomomi MaruyamaDepartment of Infectious Diseases, Gifu Prefectural Research Institute for Health and Environmental Sciences, Kakamigahara, Japan.
Yumani KubaDepartment of Medical Microbiology and zoology, Okinawa Prefectural Institute of Health and Environment, Uruma, Japan.
Wakako SakataKitakyushu City Institute of Health and Environmental Sciences, Kitakyushu, Japan.
Teruaki HigashiKitakyushu City Institute of Health and Environmental Sciences, Kitakyushu, Japan.
Naoko KiyotaDepartment of Microbiology, Kumamoto Prefectural Institute of Public-Health and Environmental Science, Uto, Japan.
Takashi SakaiDepartment of Microbiology, Kumamoto Prefectural Institute of Public-Health and Environmental Science, Uto, Japan.
Shunsuke YahiroDepartment of Microbiology, Kumamoto Prefectural Institute of Public-Health and Environmental Science, Uto, Japan.
Akira NagitaDepartment of Pediatrics, Mizushima Central Hospital, Kurashiki, Japan.
Kaori WatanabeVirology Section, Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata, Japan.
Chika HirokawaVirology Section, Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata, Japan.
Hirotsune HamabataAwase Daiichi Clinic, Okinawa, Japan.
Yoshiki FujiiDivision of Biological Science, Hiroshima City Institute of Public Health, Hiroshima, Japan.
Miwako YamamotoDivision of Biological Science, Hiroshima City Institute of Public Health, Hiroshima, Japan.
Hajime YokoiHealth Science Division, Chiba City Institute of Health and Environment, Chiba, Japan.
Misako SakamotoHealth Science Division, Chiba City Institute of Health and Environment, Chiba, Japan.
Hiroyuki SaitoDepartment of Microbiology, Akita Prefectural Research Center for Public Health and Environment, Akita, Japan.
Chihiro ShibataDepartment of Microbiology, Akita Prefectural Research Center for Public Health and Environment, Akita, Japan.
Machi InadaVirology and Epidemiology Division, Nara Prefecture Institute of Health, Sakurai, Japan.
Misako FujitaniVirology and Epidemiology Division, Nara Prefecture Institute of Health, Sakurai, Japan.
Hiroko MinagawaLaboratory of Virology, Aichi Prefectural Institute of Public Health, Nagoya, Japan.
Miyabi ItoLaboratory of Virology, Aichi Prefectural Institute of Public Health, Nagoya, Japan.
Akari ShimaMicrobiology Division, Saga Prefectural Institute of Public Health and Pharmaceutical Research, Saga, Japan.
Keiko MuranoDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroshi KatohDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Fumihiro KatoDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Makoto TakedaDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Shigeru SugaDepartment of Pediatrics, National Hospital Organization Mie National Hospital, Tsu, Japan.
Surveillance Team for Mumps Virus in Japan
National Institute of Infectious Diseases · JPNara Prefectural Institute of Public Health Research Center · JPHyogo Prefectural Institute of Environmental Sciences · JPAichi Prefectural Government · JPChiba Prefectural Institute of Public Health · JPHiroshima Institute of Technology · JPIshikawa Prefectural Nursing School · JPKanagawa Prefectural Institute of Public Health · JPThe University of Kitakyushu · JPGifu Prefectural Research Institute for Fisheries and Aquatic Environments · JPGifu Prefectural Tajimi Hospital · JPIbaraki Prefectural Police · JPMizushima Central Hospital · JPNational Center for Global Health and Medicine · JPNational Mie Hospital · JPOkinawa Prefectural Institute of Health and Environment · JPOsaka Prefectural Institute of Public Health · JPSendai Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Japan, major mumps outbreaks still occur every 4-5 years because of low mumps vaccine coverage (30-40%) owing to the voluntary immunization program. Herein, to prepare for a regular immunization program, we aimed to reveal the nationwide and long-term molecular epidemiological trends of the mumps virus (MuV) in Japan. Additionally, we performed whole-genome sequencing (WGS) using next-generation sequencing to assess results from conventional genotyping using MuV sequences of the small-hydrophobic (SH) gene. We analyzed 1,064 SH gene sequences from mumps clinical samples and MuV isolates collected from 25 prefectures from 1986 to 2017. The results showed that six genotypes, namely B (110), F (1), G (900), H (3), J (41), and L (9) were identified, and the dominant genotypes changed every decade in Japan since the 1980s. Genotype G has been exclusively circulating since the early 2000s. Seven clades were identified for genotype G using SH sequence-based classification. To verify the results, we performed WGS on 77 representative isolates of genotype G using NGS and phylogenetically analyzed them. Five clades were identified with high bootstrap values and designated as Japanese clade (JPC)-1, -2, -3, -4, -5. JPC-1 and -3 accounted for over 80% of the total genotype G isolates (68.3 and 13.8%, respectively). Of these, JPC-2 and -5, were newly identified clades in Japan through this study. This is the first report describing the nationwide and long-term molecular epidemiology of MuV in Japan. The results provide information about Japanese domestic genotypes, which is essential for evaluating the mumps elimination progress in Japan after the forthcoming introduction of the mumps vaccine into Japan's regular immunization program. Furthermore, the study shows that WGS analysis using NGS is more accurate than results obtained from conventional SH sequence-based classification and is a powerful tool for accurate molecular epidemiology studies.

Indexed as

genotypeJapanmolecular epidemiologymumps virusnext-generation sequencingphylogenetic analyseswhole-genome sequencing

Identifiers

PMID36386684
PMCPMC9650061
OpenAlexW4307511694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.